Headache

Article	Citations
Issue Information	396
Virtual issue: Kids (with headache disorders) are not just little adults (with headache disorders)	67
Issue Information	58
Predictors of migraine interictal burden: The hidden role of subjective memory complaints	55
Longitudinal assessment of comorbidities and co‐occurring conditions in adolescents with migraine: A secondary analysis of the National Longitudinal Study of Adolescent to Adult Health (Add Health)	55
Issue Information	53
Headache diagnosis and treatment: A pilot knowledge and needs assessment among physical therapists	50
Persistence, effectiveness, and tolerability of anti‐calcitonin gene–related peptide monoclonal antibodies in patients with chronic migraine	48
Artificial intelligence terminology, methodology, and critical appraisal: A primer for headache clinicians and researchers	46
Visual inspection versus spectrophotometry for xanthochromia detection in patients with sudden onset severe headache—A diagnostic accuracy study	46
Issue Information	45
Healthcare resource use and costs associated with the misdiagnosis of migraine	45
	44
Pilot study evaluating treatment with sumatriptan for moderate to severe post‐traumatic headache: A phase 2 open‐label study	40
Not their fault: Mental health characteristics of parents with migraine and the migraine status of their children	34
Headache activity associated with the 2024 North American eclipse	33
Plain Language Summary Publication: Hyperactivity of the medial thalamus in patients with photophobia‐associated migraine	33
Early effect of onabotulinumtoxinA on EEG‐based functional connectivity in patients with chronic migraine: A pilot study	29
Developing multivariable models for predicting headache improvement in patients with acute post‐traumatic headache attributed to mild traumatic brain injury: A preliminary study	29
	29
Long‐term (48 weeks) effectiveness, safety, and tolerability of erenumab in the prevention of high‐frequency episodic and chronic migraine in a real world: Results of the EARLY 2 study	29
Thank you to Dr. Dana Turner	28
Circadian functional changes of pain‐processing brainstem nuclei and implications for cluster headache: A 7 Tesla imaging study	27
Differences in circulating alpha‐calcitonin gene–related peptide levels in inflammatory bowel disease and its relation to migraine comorbidity: A cross‐sectional study	26
Heavy metal and trace element alterations in patients during a migraine attack	26

Phase Ib, open‐label, fixed‐sequence, drug–drug interaction, safety, and tolerability study between atogepant and ubrogepant in participants with a history of migraine	24
Reversible cerebral vasoconstriction syndrome after levonorgestrel‐releasing intrauterine device placement—Case report	24
	24
Trainee highlights	24
A randomized, open‐label, 5‐period crossover study evaluating the pharmacokinetics and safety of a single dose of intranasal dihydroergotamine (DHE) powder (STS101), intramuscular DHE mesylate, and li	23
Post‐traumatic headache: An unmet medical need	23
Safety, tolerability, and effectiveness of repetitive intravenous dihydroergotamine for refractory chronic migraine with cardiovascular risk factors: A retrospective study	23
RETRACTION: Effectiveness of anti‐CGRP monoclonal antibodies for persistent headaches in patients with idiopathic intracranial hypertension	23
Refractory glossopharyngeal neuralgia successfully treated with onabotulinumtoxinA: A case report	21
Visual temporal discrimination is impaired in patients with migraine without aura	21
Issue Information	20
Continuous updating of individual headache forecasting models using Bayesian methods	20
Popping the balloon: Abrupt onset of a spinal CSF leak and spontaneous intracranial hypotension in idiopathic intracranial hypertension, a case report	19
Intranasal treatment of cluster headache	19
Migraine and peripheral pain models show differential alterations in neuronal complexity	19
Eptinezumab for adolescents with chronic refractory headache: A retrospective chart review	18
Migraine screening in English and Spanish	18
Toward a better understanding of persistent headache after mild COVID‐19: Three migraine‐like yet distinct scenarios	18
Lifetime history of an anxiety or depression disorder and adherence to medications used for the acute treatment of migraine	17
Eptinezumab improved patient‐reported outcomes in patients with migraine and medication‐overuse headache: Subgroup analysis of the randomized PROMISE‐2 trial	17
	17
Trainee highlights	17
Improvements in quality of life and work productivity with up to 6 months of fremanezumab treatment in patients with episodic and chronic migraine and documented inadequate response to 2 to 4 classes	17
Author Index	16
Treatment of hemiplegic migraine with anti‐calcitonin gene‐related peptide monoclonal antibodies: A case series in a tertiary‐care headache center	16
Could osmophobia be a clinical diagnostic marker for migraine?	16
Functional magnetic resonance imaging of headache: Issues, best‐practices, and new directions, a narrative review	16
Issue Information	16
Prevalence and burden of migraine in the United States: A systematic review	15
Current practice for primary headache disorders and perspectives on peripheral nerve blocks among emergency physicians in Canada: A national survey	15
A retrospective analysis of the use of candesartan for migraine prevention in adolescents	15
Cerebrovascular reactivity to hypercapnia in patients with migraine: A dual‐echo arterial spin labeling MRI study	15
Drug‐resistant epicrania fugax: Responding to onabotulinumtoxinA	15
A retrospective cohort study of clinical factors, visit patterns, and demographic factors associated with use of remote communications in patients with headache	15
Narrative review of migraine management in patients with renal or hepatic disease	15
Comparison of migraine with left‐ versus right‐sided headache: A cross‐sectional study	15
Clinical pattern and response to treatment of primary stabbing headache: Retrospective case series study from a Portuguese tertiary hospital	15
Developing an artificial intelligence–based diagnostic model of headaches from a dataset of clinic patients' records	15
Migraine, idiopathic intracranial hypertension, and calcitonin gene‐related peptide antibodies	15
The impacts of migraine on functioning: Results from two qualitative studies of people living with migraine	14
Effects of caffeine on intracranial pressure and pain perception in freely moving rats	14
The value of the patient perspective in understanding the full burden of migraine	14
Nonspecific oral medications versus anti–calcitonin gene‐related peptide monoclonal antibodies for migraine: A systematic review and meta‐analysis of randomized controlled trials	14
Reliability, validity, and responsiveness of the Arabic version of HIT‐6 questionnaire in patients with migraine indicated for preventive therapy: A multi‐center study	14
Impact of the COVID‐19 pandemic on people living with migraine: Results of the MiCOAS qualitative study	14
Issue Information	14
Idiopathic intracranial hypertension presenting with migraine phenotype is associated with unfavorable headache outcomes	13
Do behavioral treatments work for migraine prevention?	13
Computed tomography‐guided radiofrequency ablation of cervical intervertebral discs for the treatment of refractory cervicogenic headache: A retrospective chart review	13
Did she have an epidural? The long‐term consequences of postdural puncture headache and the role of unintended dural puncture	13

Migraine and large artery atherosclerosis in young adults with ischemic stroke	13
Association of periodontal disease with migraine: A large‐scale community‐based cross‐sectional study	13
Headache response after CT‐guided fibrin glue occlusion of CSF‐venous fistulas	13
Role of memantine in the prophylactic treatment of episodic migraine: A systematic review	13
Familial hemiplegic migraine in pediatric patients: A genetic, clinical, and follow‐up study	13
Dyspareunia and pelvic pain in women with chronic migraine: A retrospective, observational analysis	12
Patient headache questionnaires can improve headache diagnosis and treatment in children	12
Ahead of the pain: Where we stand after a decade of growth in United Council for Neurologic Subspecialties‐certified headache subspecialists	12
Localization in headache medicine: A systematic approach to diagnosis	12
Low serum 25‐hydroxyvitamin D levels in migraine are not related to headache frequency: A case‐control study in patients with high‐frequency/chronic migraine	12
	12
Treatment of chronic migraine with medication overuse: A perspective	12
Beyond myths: Transformative insights into spinal cerebrospinal fluid leaks and their role in persistent headache syndromes	12
Assessing the influence of migraine on ischemic penumbra and on the prognosis of ischemic stroke: A prospective cohort study	12
Vitamin D concentrations in patients with cluster headache: A matched case–control study	12
Facial variant of epicrania fugax secondary to a cerebellopontine angle meningioma	12
Treatment of multiple sclerosis–related trigeminal neuralgia with onabotulinumtoxinA	12
Sensory hypersensitivities are associated with post‐traumatic headache‐related disability	12
The 2023 Scottsdale Headache Symposium	12
Neuralgia in the occipital region associated with ipsilateral trigeminal herpes zoster: Three case reports	11
Issue Information	11
Celebrating Headache's 2023 graduating class of Assistant Editors	11
Migraine treatment with external concurrent occipital and trigeminal neurostimulation—A randomized controlled trial	11
Hemicrania continua secondary to pituitary macroadenoma responsive to nerve blocks: A case report	11
Characteristics and natural disease history of persistent idiopathic facial pain, trigeminal neuralgia, and neuropathic facial pain	11
Telephone follow‐up on treatment and patient satisfaction at a Danish tertiary headache center: A prospective study	11
Blood pressure elevation in erenumab‐treated patients with migraine: A retrospective real‐world experience	11
Predictive models for determining treatment response to nonprescription acute medications in migraine: Results from the American Migraine Prevalence and Prevention Study	10
The headache research priorities: Research goals from the American Headache Society and an international multistakeholder expert group	10
Off‐label use of lacosamide, an alternative for the treatment of neuropathic pain	10
Physical activity pattern and migraine according to aura symptoms in the Brazilian Longitudinal Study of Adult Health (ELSA‐Brasil) cohort: A cross‐sectional study	10
Migraine in women	10
Real‐world approaches to outpatient treatment of status migrainosus: A survey study	10
The importance of patient and family perspectives of clinical decisions in pediatric headache	10
Combination CGRP monoclonal antibody and onabotulinumtoxinA treatment for preventive treatment in chronic migraine	10
Characteristics of men and women with medically diagnosed cluster headache in a national integrated healthcare system: A Veterans Health Administration cohort study	9
Aura is a symptom of a migraine attack, not its cause	9
Migraine treatment in pregnancy: A survey of comfort and treatment practices of women's healthcare providers	9
Comparative bioavailability of single‐dose zavegepant during and between migraine attacks: A phase 1, randomized, open‐label, fixed‐sequence, two‐period study	9
Basic Science Prize Award 2023	9
The 2024 Scottsdale Headache Symposium: A banner year	9
The effectiveness of parenteral agents for pain reduction in patients with migraine presenting to emergency settings: A systematic review and network analysis	9
Transient side shift of cluster headache attacks after unilateral greater occipital nerve injection	9
Use of combined hormonal contraception and stroke: A case‐control study of the impact of migraine type and estrogen dose on ischemic stroke risk	9
Issue Information	9
The effectiveness of parenteral agents to mitigate relapses after severe acute migraine headache presentations: A systematic review and network analysis	9
Narrative review of peripheral nerve blocks for the management of headache	9
Symptomatic visual snow in acute ischemic stroke: A case series	9
Beyond pain control: Outcome and treatment preferences in pediatric migraine	9
Characteristics of acute ischemic stroke and unusual aura in patients with migraine with aura	9
Anxiety, depression, and headache‐related disability in a large pediatric clinic–based sample	9
Genetically proxied liability to migraine and risk of intracranial aneurysm and subarachnoid hemorrhage	8
Effect of caffeine and caffeine cessation on cerebrovascular reactivity in patients with migraine	8
Factors to predict recurrence after epidural blood patch in patients with spontaneous intracranial hypotension	8
A narrative review of the importance of pharmacokinetics and drug–drug interactions of preventive therapies in migraine management	8
The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice	8
Normal glymphatic system function in patients with new daily persistent headache using diffusion tensor image analysis along the perivascular space	8
Characteristics associated with response to subcutaneously administered anti‐CGRP monoclonal antibody medications in a real‐world community cohort of persons living with migraine: A retrospective clin	8
Understanding the gaps in headache and migraine treatment with psychological and behavioral interventions: A narrative review	8
Normal glymphatic system function in patients with migraine: A pilot study	8
A critical appraisal of the International Classification of Headache Disorders migraine diagnostic criteria based on a retrospective multicenter cross‐sectional headache registry study in youth	8
Exploratory investigation of a patient‐informed low‐dose psilocybin pulse regimen in the suppression of cluster headache: Results from a randomized, double‐blind, placebo‐controlled trial	8
The Chronic Headache Self‐Efficacy Scale: Development and assessment of measurement properties	8
Randomized controlled pilot trial of prazosin for prophylaxis of posttraumatic headaches in active‐duty service members and veterans	8
Efficacy and safety of galcanezumab as a treatment of refractory episodic and chronic cluster headache: Case series and narrative review	8
Effect of prednisolone for the treatment of medication‐overuse headache: A 3‐month result from a multicenter REgistry for Load and management of mEdicAtion overuSE headache (RELEASE) study	7
Issue Information	7
Headache: Reflections on 2021 and looking forward to 2022	7
A post hoc analysis of migraine‐associated symptoms from the phase 3 randomized, double‐blind, sham‐controlled Trial of External trigeminal nerve stimulation for the Acute treatment of Migraine (	7
	7
Regulation of headache response and transcriptomic network by the trigeminal ganglion clock	7
	7
Remote electrical neuromodulation for migraine prevention: A double‐blind, randomized, placebo‐controlled clinical trial	7
Association between secondhand smoke exposure and severe headaches or migraine in never‐smoking adults	7
Erratum	7
Diagnosing new daily persistent headache in children and adolescents: A survey of clinicians	7
Issue Information	7
Neuromodulation for primary headache disorders: Advantages and challenges	7
Erratum	7
Assessing attack‐related fear in headache disorders—Structure and psychometric properties of the Fear of Attacks in Migraine Inventory	7

To test or not to test? Do red flags play any role?	7
Information theory and headache triggers	6
Author Index	6
Headache fellowship match shareholder insights	6
The teaching of headache medicine in France: A questionnaire‐based study	6
Erratum	6
	6
Altered resting‐state effective connectivity of trigeminal vascular system in migraine without aura: A spectral dynamic causal modeling study	6
Neuropathic changes in corneal nerve endings—A potential objective biomarker for migraine frequency and response to treatment	6
The 15‐day threshold in the definition of chronic migraine is reasonable and sufficient—Five reasons for not changing the ICHD‐3 definition	6
Indomethacin‐responsive headaches—A narrative review	6
Grand rounds education in neurology, with a focus on headache medicine	6
Issue Information	6
Intranasal treatment of cluster headache: A response	6
Shaping a new era of medicine at the American Headache Society Annual Scientific Meeting	6
Issue Information	6
Investigating the effects of weather on headache occurrence using a smartphone application and artificial intelligence: A retrospective observational cross‐sectional study	6
Improved quality of life with fremanezumab in Japanese and Korean patients with episodic and chronic migraine: Results of two multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group	6
Barriers to care in episodic and chronic migraine: Results from the Chronic Migraine Epidemiology and Outcomes Study	6
Indomethacin‐responsive idiopathic red ear syndrome: A pediatric case	6
Reduction in retinal microvascular perfusion during migraine attacks	6
Author Response to Comment on “Plasma calcitonin gene‐related peptide and nerve growth factor as headache and pain biomarkers in recently deployed soldiers with and without a recent concussion”	6
Headache rounds: Postural headache in a patient with squamous cell carcinoma	6
Is prednisone still a reasonable option in the treatment of withdrawal headache in patients with chronic migraine and medication overuse headache in the age of CGRP antibodies? A narrative	5
Correction to “Regional cerebral perfusion during the premonitory phase of triggered migraine: A double‐blind randomized placebo‐controlled functional imaging study using pseudo‐continuous arterial sp	5
Headache basic science prize	5
Fremanezumab in individuals with chronic migraine who had inadequate response to onabotulinumtoxinA and topiramate or valproic acid	5
Radiological features of patients with headache as a presenting symptom of neurosarcoidosis	5
The effect of the COVID‐19 pandemic on headache‐related disability among young adults with migraine	5
Insight of a headache medicine provider in Indian Health Service: A personal and professional observation	5
Low pulse pressure and high serum complement C1q are risk factors for hemodialysis headache: A case–control study	5
Baseline sleep quality, stress, and depressive symptoms, and subsequent headache occurrence in a six‐week prospective cohort study of patients with episodic migraine	5
Depression and anxiety in women with idiopathic intracranial hypertension compared to migraine: A matched controlled cohort study	5
Memantine for migraine—Big promise but little evidence	5
Erratum	5
Ultrasound‐guided stellate ganglion block for the treatment of migraine in elderly patients: A retrospective and observational study	5
Adaptation of the management of chronic migraine patients with medication overuse to the suspension of treatment protocols during the COVID‐19 pandemic: Lessons from a tertiary headache center in Mila	5
Impact of unilateral trigeminal neuralgia on bilateral ocular surface alterations	5
Hyperactivity of the medial thalamus in patients with photophobia‐associated migraine	5
The use of erenumab for migraine prophylaxis during pregnancy: A case report and narrative review	5
Inflammation in migraine…or not…: A critical evaluation of the evidence	5
Secondary cluster headache due to a contralateral demyelinating periaqueductal gray matter lesion	5
Systematic reviews can guide clinical practice and new research on primary headaches in pregnancy: An editorial on the 2022 American Headache Society Members' Choice Award paper	5
Autophagy may protect the brain against prolonged consequences of headache attacks: A narrative/hypothesis review	5
Comparative prevalence and characteristics of fabricated citations in large language models in headache medicine	5
Correction to “A causative role for remote dural puncture and resultant arachnoid bleb in new daily persistent headache: A case report”	5
Headache characteristics to screen for cervicocerebral artery dissection in patients with acute onset unusual headache	5
CCH attack frequency reduction after psilocybin correlates with hypothalamic functional connectivity	5
Developing and delivering a migraine disparities and diagnosis undergraduate medical educational program to underrepresented in medicine medical student members of the Student National Medical Associa	5
Sex and gender: Opportunities to expand research and understanding within headache medicine	5
Hemicrania continua in a family: A report of two cases	5
Headache and psychological variables as predictors of disability in individuals with primary headache disorders	5
Medication overuse headache in patients with chronic migraine using cannabis: A case–referent study	5
Aryl hydrocarbon receptors improve migraine‐like pain behaviors in rats through the regulation of regulatory T cell/T‐helper 17 cell‐related homeostasis	5
Bone site fracture pain after subcutaneous sumatriptan injection: A report of two cases	5
Once‐daily oral atogepant for the long‐term preventive treatment of migraine: Findings from a multicenter, randomized, open‐label, phase 3 trial	4
Correction to “Patterns of clinical and imaging presentations in patients with spontaneous intracranial hypotension due to spinal cerebrospinal fluid venous fistula: A single‐center retrospective cros	4
Virtual issue: Recent advances in pediatric headache: Bridging the data gap	4
Insights and innovations at Headache: Reflections on 2024 and looking ahead to 2025	4
Crystal‐clear days and unclear days in migraine: A population‐based study	4
A qualitative study on the long‐term effectiveness of occipital nerve stimulation in patients with chronic cluster headache	4
Frequency of headache in emergency department patients with anaphylaxis: A cross‐sectional study	4
Author Index	4
	4
Hypermobility spectrum disorders and active migraine in Israeli adolescents: A nationwide study	4
Skin wetness sensitivity across body sites commonly affected by pain in people with migraine	4
Gene polymorphism association studies in cluster headache: A field synopsis and systematic meta‐analyses	4
Osmophobia in children with headaches: A need for further studies	4
Impact of headache frequency and preventive treatment failure on quality of life, disability, and direct and indirect costs among individuals with episodic migraine in the United States	4
The impact of fear of attacks on pain‐related disability in cluster headache: Insights from the fear avoidance model	4
Popping the balloon	4
Rising migraine incidence in adolescents despite stable prevalence in the US: A call for further investigation	4
Trainee highlights	4
The “central vein sign” to differentiate multiple sclerosis from migraine	4
Comparing treatments in the emergency department: What works for migraine?	4
Visual aura without headache as a pre‐cluster symptom in episodic cluster headache: A report of two cases	4
Trainee highlights	4
Issue Information	4
Understanding the links between airborne hazards and headache disorders	4
Predictors and concomitants of the remission of frequent headache in pediatrics: A longitudinal community study	4
Patient‐reported experiences with migraine‐related cognitive symptoms: Results of the MiCOAS qualitative study	4
Anxiety and depressive symptoms and migraine‐related outcomes in children and adolescents	4
Most bothersome symptoms in patients with migraine: A hospital‐based study in Taiwan	4
Changes in use of acute and preventive medications for migraine after erenumab initiation over 12 months: A United States retrospective cohort study	4
Headache attributed to airplane travel: Time for a multicentric international survey?	4
Structural aberrations of the brain associated with migraine: A narrative review	4
Fremanezumab plus plasmapheresis in a patient with chronic migraine and myasthenia gravis: Case report of an effective treatment	4
	4
Postural orthostatic tachycardia syndrome and migraine: A narrative review	4
Common challenges in the development of prediction models	4
Preliminary exploration of a multidimensional sleep health composite in adolescent females with frequent migraine	4
	4
Efficacy of dual enkephalinase inhibition in a preclinical migraine model is mediated by activation of peripheral delta opioid receptors	4
Healthcare costs and resource utilization in patients with migraine treated with erenumab: A retrospective, non‐interventional study using claims data from the United States	3
Associations of comorbid headache disorders and depression with leisure‐time physical activity among 14,088 adults in The Brazilian Longitudinal Study of Adult Health	3